--- title: "Tender for the Supply of Services - Independent Central Review Of Primary Outcome Data For The GLO-BHNL Platform Clinical Trial - University Of Birmingham" ocid: "ocds-h6vhtk-041a2f" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-041a2f" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-041a2f.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-041a2f.json" source: "Find A Tender Service" current_stage: "Tender" buyer: "THE UNIVERSITY OF BIRMINGHAM" published: "2023-11-15" --- # Tender for the Supply of Services - Independent Central Review Of Primary Outcome Data For The GLO-BHNL Platform Clinical Trial - University Of Birmingham Buyer: THE UNIVERSITY OF BIRMINGHAM Current stage: Tender OCID: ocds-h6vhtk-041a2f [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-041a2f) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-041a2f.json) ## Summary The University of Birmingham is inviting tenders for the supply of services related to the independent central review of primary outcome data for the GLO-BHNL platform clinical trial. The procurement falls under the medical imaging services category. The project involves testing therapies for B-cell non-Hodgkin's Lymphoma, with participation from multiple countries. The total value of the contract is £5,000,000, and the contract period is from March 30, 2024, to March 30, 2031. The tender submission deadline is December 15, 2023, with the bid opening scheduled for the same day. This tender from the University of Birmingham presents an opportunity for businesses involved in providing medical imaging services and clinical trial support. Companies with expertise in cross-sectional imaging, pathology reports, and clinical trial coordination are well-suited to compete. The open procurement method allows for a transparent process with clear evaluation criteria focusing on compliance, after-sales support, delivery, sustainability, and price. Interested parties can explore the full tender details on the University of Birmingham's website for submission requirements and specifications. ## Notice The University of Birmingham invites tenders for independent central review of the primary outcome data for the clinical platform trial, Glo-BNHL. The platform aims to test a wide range of therapies over its lifetime in order to find better treatments for the rare paediatric cancer, B-cell non-Hodgkin's Lymphoma. The design allows addition of new treatment arms as novel therapies become available for testing. There are currently 2 treatment arms. Independent central review of the clinical data that informs the primary outcome measures is required, to include: cross sectional imaging by CT or MRI, PET-CT scan, bone marrow aspirate, bone marrow trephine and lumbar puncture pathology reports. Glo-BNHL is an international trial with participating sites in the UK, Europe, USA, Canada, Australia, New Zealand and Israel. A total of 45 sites will participate, with international sites' activity coordinated by 15 National Coordinating Centres. Glo-BNHL recently received ethics approval in the UK and will open later this year. Approval in the other participating nations will follow. An expedient solution to independent central review is therefore required. This project may be funded by the European Regional Development Fund (ERDF) or; - European Structural and Investment Fund (ESIF) or; - Research Councils UK (RCUK), the strategic partnership of the UK's seven Research Councils. Please refer to Appendix A via www.in-tendhost.co.uk/universityofbirmingham/aspx/Home for full specification of requirements. ### Lot Information Lot 1 The University of Birmingham invites tenders for independent central review of the primary outcome data for the clinical platform trial, Glo-BNHL. The platform aims to test a wide range of therapies over its lifetime in order to find better treatments for the rare paediatric cancer, B-cell non-Hodgkin's Lymphoma. The design allows addition of new treatment arms as novel therapies become available for testing. There are currently 2 treatment arms. Independent central review of the clinical data that informs the primary outcome measures is required, to include: cross sectional imaging by CT or MRI, PET-CT scan, bone marrow aspirate, bone marrow trephine and lumbar puncture pathology reports. Glo-BNHL is an international trial with participating sites in the UK, Europe, USA, Canada, Australia, New Zealand and Israel. A total of 45 sites will participate, with international sites' activity coordinated by 15 National Coordinating Centres. Glo-BNHL recently received ethics approval in the UK and will open later this year. Approval in the other participating nations will follow. An expedient solution to independent central review is therefore required. This project may be funded by the European Regional Development Fund (ERDF) or; - European Structural and Investment Fund (ESIF) or; - Research Councils UK (RCUK), the strategic partnership of the UK's seven Research Councils. Please refer to Appendix A via www.in-tendhost.co.uk/universityofbirmingham/aspx/Home for full specification of requirements. ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/033834-2023 | | Notice type | Tender Notice | | Procurement type | Standard | | Procurement category | Services | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | Not specified | | All stages | Tender | ## Dates | Field | Value | | --- | --- | | Publication date | 15 Nov 2023 | | Submission deadline | 15 Dec 2023 | | Future notice date | Not specified | | Award date | Not specified | | Contract period | 30 Mar 2024 - 30 Mar 2031 | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £5,000,000 | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Active | | Lots status | Active | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | THE UNIVERSITY OF BIRMINGHAM | | Locality | BIRMINGHAM | | Post town | Birmingham | | Postcode | B15 2TT | | Country | England | | ITL 1 | TLG West Midlands (England) | | ITL 2 | TLG3 West Midlands | | ITL 3 | TLG31 Birmingham | | Local authority | Birmingham | | Electoral ward | Edgbaston | | Westminster constituency | Birmingham Edgbaston | | Delivery location | TLG3 West Midlands | ## CPV Codes ### Divisions - 85 - Health and social work services ### Codes - 85150000 - Medical imaging services ## Release History - 15 Nov 2023 at 17:00 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/033834-2023 ## Notice URLs - http://www.in-tendhost.co.uk/universityofbirmingham/aspx/Home - https://www.birmingham.ac.uk/ ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-041a2f. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-041a2f.json.